Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Clinical trial NCT02429518 · COMPLETED

Trial details

NCT number: NCT02429518
Sponsor: Knight Therapeutics (USA) Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Mucocutaneous Leishmaniasis

Start date: 2015-12-01
Primary completion: 2017-06-06
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.